arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CHEMED CORP

CHE
$552.39 ▲ +3.44 (+0.63%) at close
Healthcare ·Services-Home Health Care Services ·USServices-Home Health Care Services
19 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

CHEMED CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $8.0B
Dividend Yield 0.40%
Revenue Growth 4.1%
Op. Margin 13.4%
ROIC 25.7%
FCF / Share $22.61
Trailing P/E 30.0x
Price / Book 8.1x
FCF Yield 4.1%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.53B
↑ +4.1%
Net Income Profit after all expenses
$265.24M
↓ -12.2%
Operating Margin Operating profit as % of sales
13.4%
↓ -11.3% 64th
FCF / Share Free cash flow per share
$22.61
↓ -7.7%
Long-Term Debt Long-term obligations
$97.50M
↓ -47.3%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
66
Returns
91
Financial Health
96
Cash Quality
74

Dividend History

Dividend / share · sourced from SEC filings
$2.20 Latest / share
+22.2% YoY
+9.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 72 quarters